Tibsovo

04 February 2026 - 00:20

العربیة
فارسی
افغانستان

EAEU, good opportunity to Iran's trade: Interior Minister
Iran to produce whole needed medicines: Health Minister
Fires engulf Saudi Arabia's oil facilities after drone attacks
Sanctions crime against humanity: Iran’s UN Rep.
Iran's nuclear program transparent: Envoy
Breaking news: Trump fires John Bolton
Indian forces attack on Kashmiris mourning for Imam Hussein
Iranians holding Ashura mourning for Imam Hussein
Saudis seek to enrich uranium, build firs reactor
Iranians attend processions in millions to mark Tasua
Acting Director General of IAEA arrives Iran
IAEA acting Director General to come Iran
Third step: Iran officially informs EU of plan to expand nuclear R&D
Spokesman announces details of FM Zarif letter to Mogherini
Iran expands nuclear R&D program: Rouhani
Iran goes ahead in space tech, despite US sanctions: ISA
Resistance Front undermining Israeli regime power: Top commander
Iran: 7 crew members of detained UK ship freed
Agreement with Europe unlikely, Iran to announce 3rd step on JCPOA: Rouhani

Tags - Tibsovo

Tibsovo approved for acute myeloid leukemia

TEHRAN, July 23 -Tibsovo tablets have been approved by the U.S. Food and Drug Administration to treat relapsed or refractory acute myeloid leukemia among people with a defective IDH1 gene.

News ID: 26396 Publish Date : 2018/07/23